Correlation Between Cerevel Therapeutics and Prometheus Biosciences

Can any of the company-specific risk be diversified away by investing in both Cerevel Therapeutics and Prometheus Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cerevel Therapeutics and Prometheus Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cerevel Therapeutics Holdings and Prometheus Biosciences, you can compare the effects of market volatilities on Cerevel Therapeutics and Prometheus Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cerevel Therapeutics with a short position of Prometheus Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cerevel Therapeutics and Prometheus Biosciences.

Diversification Opportunities for Cerevel Therapeutics and Prometheus Biosciences

-0.16

Correlation Coefficient

Cerevel Therapeutics  Prometheus Biosciences

Good diversification

The 3 months correlation between Cerevel and Prometheus is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Cerevel Therapeutics Holdings and Prometheus Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prometheus Biosciences and Cerevel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cerevel Therapeutics Holdings are associated (or correlated) with Prometheus Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prometheus Biosciences has no effect on the direction of Cerevel Therapeutics i.e., Cerevel Therapeutics and Prometheus Biosciences go up and down completely randomly.

Pair Corralation between Cerevel Therapeutics and Prometheus Biosciences

If you would invest  19,992  in Prometheus Biosciences on September 12, 2024 and sell it today you would earn a total of  0.00  from holding Prometheus Biosciences or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Cerevel Therapeutics Holdings  vs.  Prometheus Biosciences

Cerevel Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cerevel Therapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Cerevel Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Prometheus Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Prometheus Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental indicators, Prometheus Biosciences is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Cerevel Therapeutics and Prometheus Biosciences

The main advantage of trading using opposite Cerevel Therapeutics and Prometheus Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cerevel Therapeutics position performs unexpectedly, Prometheus Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prometheus Biosciences will offset losses from the drop in Prometheus Biosciences' long position.

The idea behind Cerevel Therapeutics Holdings and Prometheus Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.